Skip to content

Analysis of Risk Factors for myelosuppression in Breast Cancer Patients undergoing chemotherapy and Construction of a predictive model

Analysis of Risk Factors for myelosuppression in Breast Cancer Patients undergoing chemotherapy and Construction of a predictive model

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115348
Enrollment
Unknown
Registered
2025-12-25
Start date
2025-12-25
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone marrow suppression caused by chemotherapy for malignant breast tumors

Interventions

Myelosuppression group :None
non-myelosuppression group:None

Sponsors

Fuyang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with breast cancer through histopathological examination in accordance with the Chinese Anti-Cancer Association's Guidelines for the Diagnosis and Treatment of Breast Cancer; 2. Undergoing chemotherapy; 3. Aged >= 18 years; 4. Conscious and able to cooperate with the survey.

Exclusion criteria

Exclusion criteria: 1.Combined with liver and kidney failure, other primary tumors or systemic infectious diseases; 2. Bone marrow suppression occurred before chemotherapy or drugs that increase white blood cells were used preventively; 3.Currently participating in other studies affecting bone marrow suppression; 4.Receive other treatments (such as endocrine therapy, immunotherapy, etc.); 5.Those who interrupt or give up chemotherapy; 6. The case data is incomplete.

Design outcomes

Primary

MeasureTime frame
Risk Factor Questionnaire; ; Myelosuppression investigation Form;

Countries

China

Contacts

Public ContactZhang Ruixin

Fuyang People's Hospital

1007559983@qq.com+86 558 3010819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026